Cloud-clone
SKU:MAF709Hu21
Monoclonal Antibody to Peptidyl Arginine Deiminase Type IV (PADI4)
Monoclonal Antibody to Peptidyl Arginine Deiminase Type IV (PADI4)
Couldn't load pickup availability
Western blotting: 0.2-2µg/mL;1:500-5000
Immunohistochemistry: 5-20µg/mL;1:50-200
Immunocytochemistry: 5-20µg/mL;1:50-200
Optimal working dilutions must be determined by end user.
Product No.
MAF709Hu21
Organism Species
Homo sapiens (Human).
Source
Monoclonal antibody preparation
Host
Mouse
Potency (Clone Number)
C5
Ig Isotype
IgG2b Kappa
Purification
Protein A + Protein G affinity chromatography
Label
None
Immunogen
RPF709Hu01-Recombinant Peptidyl Arginine Deiminase Type IV (PADI4)
Buffer Formulation
0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.
Traits
Liquid
Concentration
1mg/ml
Organism Species More
n/a
Applications
WB
If the antibody is used in flow cytometry, please check FCM antibodies.
UOM
20µl 100µl 200µl 1ml 10ml
SPECIFITY
The antibody is a mouse monoclonal antibody raised against PADI4. It has been selected for its ability to recognize PADI4 in immunohistochemical staining and western blotting.
USAGE
Western blotting: 0.01-3µg/mL;
Optimal working dilutions must be determined by end user.
STORAGE
Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
STABILITY
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
| Magazine | Citations |
| Arthritis Res Ther. | Enhanced neutrophil extracellular trap generation in rheumatoid arthritis: analysis of underlying signal transduction pathways and potential diagnostic utility Pubmed:Pmc4229860 |
| Journal of Molecular Cell Biology | Peptidylarginine deiminase 4 concentration, but not polymorphisms, is associated with ICU mortality in septic shock patients Pubmed:30044533 |
| Journal of Inflammation Research | Release of active peptidylarginine deiminase into the circulation during acute inflammation induced by coronary artery bypass surgery Pubmed: 31213874 |
| Revista da Associacao Medica Brasileira | Evaluation of peptidylarginine deiminase 4 and PADI4 polymorphisms in sepsis-induced acute kidney injury |
| Catalog No. | Related products for research use of Homo sapiens (Human) Organism species | Applications (RESEARCH USE ONLY!) |
| RPF709Hu01 | Recombinant Peptidyl Arginine Deiminase Type IV (PADI4) | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAF709Hu01 | Polyclonal Antibody to Peptidyl Arginine Deiminase Type IV (PADI4) | WB; IHC; ICC; IP. |
| MAF709Hu21 | Monoclonal Antibody to Peptidyl Arginine Deiminase Type IV (PADI4) | WB |
| MAF709Hu22 | Monoclonal Antibody to Peptidyl Arginine Deiminase Type IV (PADI4) | WB; IHC; ICC; IP. |
| MAF709Hu23 | Monoclonal Antibody to Peptidyl Arginine Deiminase Type IV (PADI4) | WB; IHC; ICC; IP. |
| MAF709Hu24 | Monoclonal Antibody to Peptidyl Arginine Deiminase Type IV (PADI4) | WB; IHC; ICC; IP. |
| SEF709Hu | ELISA Kit for Peptidyl Arginine Deiminase Type IV (PADI4) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMF709Hu | Magnetic Luminex Assay Kit for Peptidyl Arginine Deiminase Type IV (PADI4) ,etc. | Magnetic Luminex Assay for Antigen Detection. |
Share
